KLBF.JK - PT Kalbe Farma Tbk.

Jakarta - Jakarta Delayed price. Currency in IDR
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
28,344,270,062
28,933,502,647
26,261,194,512
23,112,654,991
22,633,476,361
Cost of revenue
16,605,209,120
17,229,436,210
14,977,410,271
12,866,332,497
12,390,008,590
Gross profit
11,739,060,942
11,704,066,436
11,283,784,241
10,246,322,494
10,243,467,771
Operating expenses
Research development
530,651,618
288,343,543
532,792,581
483,764,333
543,456,492
Selling general and administrative
4,026,132,191
4,050,705,204
3,860,916,638
3,347,847,805
3,600,282,082
Total operating expenses
7,487,675,121
7,472,198,441
7,282,062,376
6,700,398,323
6,938,980,520
Operating income or loss
4,251,385,821
4,231,867,996
4,001,721,865
3,545,924,171
3,304,487,250
Interest expense
35,991,237
41,225,900
45,485,900
75,836,781
31,055,146
Income before tax
4,404,059,613
4,458,896,905
4,143,264,635
3,627,632,575
3,402,616,825
Income tax expense
962,147,389
1,008,813,493
911,256,951
828,010,059
865,015,001
Income from continuing operations
3,441,912,224
3,450,083,412
3,232,007,683
2,799,622,516
2,537,601,824
Net income
3,381,400,892
3,382,209,769
3,183,621,310
2,733,259,865
2,506,764,572
Net income available to common shareholders
3,381,400,892
3,382,209,769
3,183,621,310
2,733,259,865
2,506,764,572
Basic EPS
-
72.71
67.92
58.31
53.48
Diluted EPS
-
72.71
67.92
58.31
53.48
Basic average shares
-
46,515,941
46,872,947
46,874,633
46,875,122
Diluted average shares
-
46,515,941
46,872,947
46,874,633
46,875,122
EBITDA
-
4,887,362,735
4,536,831,894
4,042,348,280
3,703,932,592